 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Connetics Corporation
 |
Connetics Corporation |
 |
 |
 |
PROFILE |
 |
"When immune systems go haywire" isn't a Fox special; it's the niche for Connetics. The firm specializes in treatments for autoimmune diseases involving connective tissues, including dermatosis, scleroderma, a thickening of skin and organs. It develops drugs based on relaxin, a natural substance that promotes connective tissue remodeling; its drug candidates target cardiovascular and renal diseases and infertility. Connetics has discontinued disappointing relaxin trials for scleroderma. It markets such dermatology products as Luxiq, for scalp dermatoses; it sold rheumatoid arthritis drug Ridaura to Prometheus Laboratories. The firm's development partners include Celltech Group and F. H. Faulding.
COMPETITION |
 |
Amarillo Biosciences, Inc. (AMAR)
Angiotech Pharmaceuticals, Inc. (ANPI)
Anika Therapeutics, Inc. (ANIK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 40.80
1-Yr. Sales Growth: 51.7%
Employees: 136
Revenue per employee: $300,000.00
KEY PEOPLE |
 |
Thomas G. Wiggans
CEO
John L. Higgins
CFO
CONTACT INFO |
 |
3400 W. Bayshore Rd.
Palo Alto, CA 94303
US
Phone: 650-843-2800
Fax: 650-843-2899
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |